Clinical Trial Update: A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028) [Phase 3]

View source ↗

Summary

Phase 3 trial update on the safety and efficacy of omarigliptin (MK-3102) in adults with type 2 diabetes and inadequate glycemic control; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Omarigliptin (omarigliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2016-07-18